Azithromycin/hydroxychloroquineVentricular arrhythmias following off-label use in COVID-19: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1819卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82604-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[1] Azithromycin/favipiravir/hydroxychloroquineVentricular tachycardia and off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1819 (1) : 59 - 59
[2] Azithromycin/hydroxychloroquineQTc prolongation following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1842 (1) : 83 - 83
[3] Azithromycin/hydroxychloroquineCardiac arrest following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 74 - 74
[4] Lopinavir/ritonavirVarious toxicities following off-label use in COVID-19: 4 case reports
[J]. Reactions Weekly, 2021, 1843 (1) : 230 - 230
[5] Azithromycin/ceftriaxone/remdesivirBradycardia and lack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1896 (1) : 79 - 79
[6] Azithromycin/chloroquineVarious toxicities following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2021, 1848 (1) : 83 - 83
[7] TocilizumabViral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1813 (1) : 220 - 220
[8] Azithromycin/antiretrovirals/tacrolimusAcute kidney injury following off-label use and interaction, and COVID-19 pneumonia: case report
[J]. Reactions Weekly, 2020, 1815 (1) : 68 - 68
[9] RuxolitinibVarious toxicities following off-label use : 19 case reports
[J]. Reactions Weekly, 2021, 1872 (1) : 447 - 447
[10] ClozapineAgranulocytosis following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1924 (1) : 164 - 164

← 1 2 3 4 5 →